Latest Articles

Publication Date
ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer - OncLive

ASCENT-Gyn-01 Trial of Sacituzumab Govitecan Aims to Validate Clinical Utility of TROP2 ADCs in Pretreated Endometrial Cancer OncLive

Published: Sept. 26, 2025, 7:40 p.m.
UNM’s Kimberly Leslie awarded $12.9M NCI grant to study endometrial cancer - The Cancer Letter

UNM’s Kimberly Leslie awarded $12.9M NCI grant to study endometrial cancer The Cancer Letter

Published: Sept. 26, 2025, 7:28 p.m.
What's the Best Method for Endometrial Cancer Surveillance? - Cancer Nursing Today

What's the Best Method for Endometrial Cancer Surveillance? Cancer Nursing Today

Published: Sept. 26, 2025, 5:47 p.m.
KU Cancer Center Evaluating Progestin Use to Treat Endometrial Cancer | Newswise - Newswise

KU Cancer Center Evaluating Progestin Use to Treat Endometrial Cancer | Newswise Newswise

Published: Sept. 26, 2025, 1:45 p.m.
What causes endometriosis? Scientists are closer to finding out - WRVO Public Media

What causes endometriosis? Scientists are closer to finding out WRVO Public Media

Published: Sept. 26, 2025, 1:22 p.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia

Published: Sept. 26, 2025, 11:03 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa

Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India

Published: Sept. 26, 2025, 10:48 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com

Published: Sept. 26, 2025, 10:25 a.m.
Endometriosis testing specialist expands reach with adolescent clinic in Manchester - NationalWorld

Endometriosis testing specialist expands reach with adolescent clinic in Manchester NationalWorld

Published: Sept. 26, 2025, 10:19 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!